SANUWAVE Health (SNWV) Earnings Analysis
SANUWAVE Health (SNWV) next reports earnings on 2026-08-14, consensus EPS -0.03 USD. Last quarter (2026-03-26) it missed with EPS 0.03 USD vs 0.17 USD est (-82.4%). It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E 3.39.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SNWV next report earnings?
| Next earnings date | 2026-08-14 |
|---|---|
| Consensus EPS estimate | -0.03 USD |
| Revenue estimate | 0.01B |
SNWV earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-26 | 0.03 USD | 0.17 USD | -82.4% | Miss |
| 2025-11-07 | 0.46 USD | 0.32 USD | +43.8% | Beat |
| 2025-08-08 | 0.01 USD | -0.09 USD | +111.1% | Beat |
| 2025-05-09 | -0.66 USD | n/a | n/a | n/a |
| 2025-03-20 | -1.21 USD | n/a | n/a | n/a |
| 2024-08-12 | 3.7 USD | n/a | n/a | n/a |
Beat rate: 2/3 (67%) over reported quarters with consensus data.
SNWV valuation and analyst view
| Trailing P/E | 3.39 |
|---|---|
| Trailing EPS | 1.868 USD |
| Price / book | 27.81 |
| Dividend yield | 0.00% |
| Market cap | 0.05B |
| Analyst consensus | Buy (2 buy / 0 hold / 0 sell) |
| Avg price target | 54.33 USD |
Related research pages
Frequently asked questions
When is SANUWAVE Health (SNWV)'s next earnings date?
SANUWAVE Health is next scheduled to report on 2026-08-14, with a consensus EPS estimate of -0.03 USD and revenue estimate of 0.01B.
Did SNWV beat earnings last quarter?
In its 2026-03-26 report, SNWV posted EPS of 0.03 USD versus a 0.17 USD estimate — a miss of 82.4%.
What is SNWV's earnings track record?
Over the last 3 reported quarters with consensus data, SNWV beat estimates 2 times (67%).
What is SNWV's current P/E ratio and EPS?
SNWV trades at a trailing P/E of 3.39 on trailing EPS of 1.8682128873398953 USD.
What do analysts rate SNWV?
Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 54.33 USD.